Beta-blockers, calcium channel blocker and angiotension converting enzyme (ACE) inhibitors are recommended by WHO because of their definitely antihypertensive efficacy, few adverse side effects, organ protection and risk factors reduction related to hypertension [9, 26, 27]. The gene discussed is ACE; the disease is Hypertension.